✦ LIBER ✦

13-Cis-retinoic acid and alphainterferon in advanced squamous cell cancer of the oesophagus

✍ Scribed by T.C. Kok; A. van der Gaast; T.A.W. Splinter

Book ID: 117663619
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 240 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(96)00362-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

943 Toxicity of 13-CIS-retinoic acid, IF

943 Toxicity of 13-CIS-retinoic acid, IFN-α and simultaneous radiotherapy in advanced squamous cell carcinomas

✍ W. Hoffmann; M. Schiebe; P. Himle; I. Adamietz; S. Mose; M. Bamberg 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 156 KB

13-CIS retinoic acid and interferon-α ±

13-CIS retinoic acid and interferon-α ± irradiation in the treatment of squamous-cell carcinomas

✍ Wolfgang Hoffmann; Martina Schiebe; Peter Hirnle; Rainer Souchon; Michael Clemen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 43 KB 👁 1 views

Pre-clinical data indicate that retinoid/interferon combinations have significant activity in modulating malignant cell growth, differentiation and programmed cell death in different hematologic and solid tumor systems . Clinically, the combination of 13-cis retinoic acid (13cRA) and interferon-a (I

13-cis-Retinoic acid in chemopreventiion

13-cis-Retinoic acid in chemopreventiion of superficial bladder cancer

✍ Geroge R. Prout Jr.; Bruce A. Barton; W. W. Kontz Jr.; S. Loening; M. J. Flangan 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB

Animal studies indicate that 13-cis-retinoic acid (CRA) inhibits bladder tumor growth and is effective in treating patients with serious dermatologic disorders. A trial of CRA in patients at high risk for recurrent Ta, T l tumors was initiated at an experimental dose of 0.5 mg/kg/d in three divided

Differences in the pharmacokinetics of 1

Differences in the pharmacokinetics of 13-CIS retinoic acid in cancer patients

✍ A.R. Waladkhani; M.R. Clemens 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 35 KB 👁 2 views

Pharmacokinetic studies of 13-cis retinoic acid (13cRA) and all-trans retinoic acid (ATRA), the 2 most commonly used retinoids, have suggested significant differences in the disposition of these compounds despite their structural similarity. In vivo treatment with 13cRA has been associated with 20-3

178. Phase-II trial of 13-cis retinoic a

178. Phase-II trial of 13-cis retinoic acid (13cRA) plus interferon-α (IFN) in locally-advanced squamous cell carcinoma (SCC) of the cervix

✍ Lippman, SM; Kavanagh, JJ; Paredes, M; Hong, WK; Lotan, R; Hua, H; Hittelman, W; 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 113 KB

The Effects of 13-cis Retinoic Acid on S

The Effects of 13-cis Retinoic Acid on Squamous Cell Carcinoma Proliferation and Adhesion to Extracellular Matrix Proteins

✍ Matthew T. Speyer; Jon A. Jackson; Brian B. Burkey 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB